Back to results
US 2026/0174692 A1Published application
Aerosol composition
AssigneeUPyTher B.V.
InventorsPeter Paul Kathleen Hubert Fransen, Patricia Yvonne Wilhelmina Dankers, Helena Anna Braet, Katrien Free Remaut, Stefaan Cornelis De Smedt
Life of this patent
Estimating the term…
Abstract
The present invention relates to an aerosol composition comprising a UPy-PEG polymer and a pharmaceutically acceptable carrier for use in a method of treatment or prevention of a disease of the peritoneal cavity, wherein the treatment comprises administration of the aerosol composition to the peritoneal cavity by nebulization. The invention also relates to a drug nebulizing device for such use.
Claims20
An aerosol composition comprising:
- a UPy-PEG polymer having hydrophobic hard blocks covalently bonded with hydrophilic soft blocks wherein the hydrophobic hard blocks comprise 2-ureido-4 [1H]-pyrimidinone (UPy) moieties and aliphatic spacers and the hydrophilic soft blocks comprise polyethylene glycol moieties;
- and
- a pharmaceutically acceptable carrier
- wherein the aerosol composition comprises:
- a viscosity of 1 to 500 mPa·s, preferably 1 to 100 mPa·s over a temperature range of 15 to 25° C. and a pH range of 8.5 to 14,
- a viscosity of 1 to 20 mPa·s, preferably 1 to 5 mPa·s over a temperature range of 35 to 50° C. and a pH range of 8.5 to 14,
- a viscosity of at least 100 mPa·s, preferably at least 1000 mPa·s over a temperature range of 35 to 40° C. and a pH range of 6 to 8,
- wherein the viscosity is measured at shear rate 1 s−1,
- wherein the aerosol composition is configured for use in a method of treatment or prevention of a disease of the peritoneal cavity, the treatment or prevention comprising administration of the aerosol composition to the peritoneal cavity by nebulization.
6 more elements
Dependencies are inferred from the claim text.